Skip to content
777 Sourcing.

Capability

reformulation of standard of care treatments

Suppliers
1
States & provinces
1
Countries
1

1 reformulation of standard of care treatments supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

BioLink is a specialty pharmaceutical company focused on the development and commercialization of patented treatments to meet the needs of underserved patient populations. It builds on reformulations of gold standards of care to provide novel treatments eligible for approval using 505(b)(2) New Drug Applications. Its product Phosveda addresses management of hyperphosphatemia in ESRD/dialysis patients.

505(b)(2) New Drug Applicationscommercialization of patented treatmentsdrug development

Related capabilities

Other processes offered by the shops that list reformulation of standard of care treatments.

Browse all capabilities